Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
Articolo
Data di Pubblicazione:
2022
Citazione:
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism? / M. Mapelli, I. Mattavelli, E. Salvioni, C. Banfi, S. Ghilardi, F. De Martino, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Basile, M.I.F. Branco Pires, V. Sassi, B. Nusca, C. Vignati, M. Contini, C. Sforza, M.L. Biondi, P. Perrone Filardi, P. Agostoni. - In: FRONTIERS IN CARDIOVASCULAR MEDICINE. - ISSN 2297-055X. - 9:(2022), pp. 971108.1-971108.10. [10.3389/fcvm.2022.971108]
Abstract:
Little is known about the mechanism underlying Sacubitril/Valsartan effects in patients with heart failure (HFrEF). Aim of the study is to assess hemodynamic vs. non-hemodynamic Sacubitril/Valsartan effects by analyzing several biological and functional parameters.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Sacubitril/Valsartan; biomarkers; heart failure; hemodynamics; pleiotropic; surfactant binding proteins
Elenco autori:
M. Mapelli, I. Mattavelli, E. Salvioni, C. Banfi, S. Ghilardi, F. De Martino, P. Gugliandolo, V. Mantegazza, V. Volpato, C. Basile, M.I.F. Branco Pires, V. Sassi, B. Nusca, C. Vignati, M. Contini, C. Sforza, M.L. Biondi, P. Perrone Filardi, P. Agostoni
Link alla scheda completa:
Link al Full Text: